Delivery Order SPE2DB22D2103-SPE2DB24FR9KS

Award Date 5/29/24
Potential Completion Date 6/20/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the U.S. Department of Defense (DoD) worldwide. The contract, valued at up to $999,999,999.00, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to deliver specialty, brand name, generic, and...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a federal contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a comprehensive range of pharmaceutical products and medical supplies. The contract, valued at up to $999,999,999.00 through December 31, 2025, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to provide specialty, brand name, generic, and over-the-counter medications, as...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The contract is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. It serves as the primary vehicle for Amerisourcebergen to deliver specialty,...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply the Defense Logistics Agency (DLA) with a comprehensive range of pharmaceutical products and medical supplies. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, making it the primary vehicle for Amerisourcebergen to deliver medications, including specialty, brand name, generic, and over-the-counter drugs, as well as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The contract is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. Under this contract, Amerisourcebergen will deliver specialty, brand name, generic, and...
The U.S. government agency Defense Logistics Agency (DLA) awarded a federal contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, which has an Indefinite Delivery Contract (IDC) vehicle valued up to $999,999,999.00 through December 31, 2025, enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. This single-award IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. Under this contract, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a wide range of medical products and prescription drugs to the Department of Defense (DoD) and other government agencies. The contract, valued at up to $999,999,999.00 through December 31, 2025, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive selection of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense, to the pharmaceutical distribution company Amerisourcebergen Drug Corp. The contract, valued at up to $999,999,999.00 through December 31, 2025, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $999,999,999.00, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR9KS
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, and serves as the primary vehicle for Amerisourcebergen to deliver specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits to DLA facilities globally. This contract does not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 8/28/24, 11:24 AM